VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
75 hedge funds and large institutions have $105M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 31 increasing their positions, 8 reducing their positions, and 17 closing their positions.
2,050% more call options, than puts
Call options by funds: $86K | Put options by funds: $4K
288% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 8
78% more capital invested
Capital invested by funds: $58.8M → $105M (+$45.7M)
29% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 17
7% more funds holding
Funds holding: 70 → 75 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.33M |
| 2 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
+$1.04M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$720K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$519K |
| 5 |
State Street
Boston,
Massachusetts
|
+$406K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$942K |
| 2 |
Blackstone Inc
New York
|
-$879K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$746K |
| 4 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$720K |
| 5 |
GAI
General American Investors
New York
|
-$633K |
VBIV Hedge Fund Activity: Q4 2019 in Review
75 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q4 2019, worth a combined $105M — up 78% from $58.8M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new VBIV positions and 17 closed out — a net gain of 5 holders — while 31 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $4.33M. The largest seller was 683 Capital Management, exiting entirely with an estimated $942K sold.
- 75 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q4 2019, up from 70 in Q3 2019.
- Funds reported $105M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q4 2019, up 78% quarter-over-quarter.
- 22 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q4 2019 and 17 closed out, a net change of +5 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q4 2019 was BlackRock, an estimated $4.33M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q4 2019 was 683 Capital Management, an estimated $942K sold.
Based on aggregated 13F filings for Q4 2019.